Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lorazepam dosing strategies for alcohol withdrawal
NCT00249366Phase 4Completed
- Sponsor
- Virginia Commonwealth University
- Start
- Apr 2001
- Primary completion
- May 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lorazepam in alcohol withdrawal syndrome (AWS), sponsored by Virginia Commonwealth University. Started Apr 2001; status: completed.
02
Drugs
lorazepam
03
Conditions
alcohol withdrawal syndrome (AWS)
Beyond the preview
Go deeper on NCT00249366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00249366.